Exportin-1/CRM1 (D6V7N) Rabbit mAb #46249
- WB
- IP
- IHC
- IF
Supporting Data
REACTIVITY | H M Mk |
SENSITIVITY | Endogenous |
MW (kDa) | 123 |
Source/Isotype | Rabbit IgG |
Application Key:
- WB-Western Blotting
- IP-Immunoprecipitation
- IHC-Immunohistochemistry
- IF-Immunofluorescence
Species Cross-Reactivity Key:
- H-Human
- M-Mouse
- Mk-Monkey
Product Information
Product Usage Information
Application | Dilution |
---|---|
Western Blotting | 1:1000 |
Immunoprecipitation | 1:50 |
Immunohistochemistry (Paraffin) | 1:300 - 1:1200 |
Immunofluorescence (Immunocytochemistry) | 1:400 - 1:1600 |
Storage
For a carrier free (BSA and azide free) version of this product see product #49000.
Protocol
Specificity / Sensitivity
Species Reactivity:
Source / Purification
Background
Inhibition of nuclear export has been pursued for therapeutic application since the finding that leptomycin B could suppress HIV replication by suppressing the ability of exportin-1 to export the HIV-1 protein Rev (2, 10). Overexpression of exportin-1 has been associated with poor prognosis in various cancer types (11-13). Genomic approaches and development of inhibitors have identified exportin-1 as a druggable target (14-16). The use of various inhibitors of exportin-1 is also being explored in various antiviral therapies (17-18).
- Xu, D. et al. (2012) Mol Biol Cell 23, 3673-6.
- Ossareh-Nazari, B. et al. (1997) Science 278, 141-4.
- Fukuda, M. et al. (1997) Nature 390, 308-11.
- Kutay, U. and Güttinger, S. (2005) Trends Cell Biol 15, 121-4.
- Dong, X. et al. (2009) Nat Struct Mol Biol 16, 558-60.
- Vogt, P.K. et al. (2005) Cell Cycle 4, 908-13.
- Craig, E. et al. (2002) EMBO J 21, 31-42.
- Thomas, F. and Kutay, U. (2003) J Cell Sci 116, 2409-19.
- Golomb, L. et al. (2012) Mol Cell 45, 222-32.
- Wolff, B. et al. (1997) Chem Biol 4, 139-47.
- Noske, A. et al. (2008) Cancer 112, 1733-43.
- Shen, A. et al. (2009) Neurosurgery 65, 153-9; discussion 159-60.
- Yao, Y. et al. (2009) Oncol Rep 21, 229-35.
- Schmidt, J. et al. (2013) Leukemia 27, 2357-65.
- Boyle, S.M. et al. (1999) J Virol 73, 6872-81.
- Walker, C.J. et al. (2013) Blood 122, 3034-44.
- Yadav, V. et al. (2016) Virusdisease 27, 357-368.
- Chutiwitoonchai, N. et al. (2017) Virology 507, 32-39.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.